Michael Lindemann

Title: Michael Lindemann: Innovator in Digital Qualimetric Biomarkers

Introduction

Michael Lindemann is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of digital qualimetric biomarkers, particularly in assessing cognition and movement diseases or disorders. With a total of 3 patents, his work is paving the way for advancements in medical technology.

Latest Patents

Lindemann's latest patents include innovative methods for assessing cognition and movement diseases. One of his patents discloses a method for assessing a cognition and movement disease or disorder in a subject. This method involves determining a qualimetric activity parameter for cognition and fine motoric activity measurements from a dataset obtained using a mobile device. The qualimetric activity parameter is then compared to a reference to assess the disease or disorder. Another patent focuses on identifying whether a subject will benefit from therapy for such diseases, utilizing a mobile device equipped with a processor, sensor, and database.

Additionally, he has developed a method for automatically assessing information processing speed in a test subject. This method determines various qualimetric activity parameters related to sensorial transmission, cognition, and motoric output activity. By comparing these parameters, the information processing speed can be assessed, which aids in determining cognitive impairment.

Career Highlights

Throughout his career, Michael Lindemann has worked with prominent companies such as Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has contributed to his expertise in the field of medical technology and innovation.

Collaborations

Lindemann has collaborated with notable individuals in his field, including Mike Baker and Shibeshih Mitiku Belachew. These collaborations have further enhanced his research and development efforts.

Conclusion

Michael Lindemann is a pioneering inventor whose work in digital qualimetric biomarkers is making a significant impact in the assessment of cognition and movement diseases. His innovative methods and patents are essential contributions to the medical technology landscape.